Meeting
2017 ASCO Annual Meeting
Circulating tumor DNA analysis using targeted sequencing of 508 clinically actionable genes in patients with high grade serous ovarian cancer.
Authors
Anniina Färkkilä
University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Anniina Färkkilä , Liina Salminen , Kaisa Huhtinen , Sakari Hietanen , Seija Elisa Grenman , Rainer Lehtonen , Johanna Hynninen , Olli Carpen , Sampsa Hautaniemi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5582)
DOI
10.1200/JCO.2017.35.15_suppl.5582
Abstract #
5582
Poster Bd #
404
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Clinical implications of drug-metabolizing genes CYP3A4 and GSTP1 single nucleotide polymorphisms in oral cancer patients undergoing induction chemotherapy.
First Author: Pranab Kumar Sahoo
Poster
2014 ASCO Annual Meeting
Association of genetic variants involved in drug metabolism and transport with efficacy and toxicity of chemotherapeutic treatment in osteosarcoma patients.
First Author: Hanneke I. Vos
Poster
2012 ASCO Annual Meeting
The role of phase I clinical trials in advanced malignant melanoma: Retrospective analysis of CTEP-sponsored trials 1995-2011.
First Author: Jason John Luke
Poster
2023 ASCO Breakthrough
The impact of low muscle mass and strength on chemotherapy toxicity in women with early breast cancer.
First Author: Andree Kurniawan Jr.